PharmaShots | Incisive News in 3 Shots

Subscribe Now

CNS Pharmaceuticals

CNS Pharmaceuticals Reports First Patient Enrollment in Pivotal Global Trial of Berubicin for Recurrent Glioblastoma Multiforme in Spain

CNS Pharmaceuticals Reports First Patient Enrollment in Pivotal Global Trial of Berubicin for Recurrent Glioblastoma Multiforme in...

February 8, 2023

CNS Pharmaceuticals Initiates P-Ib/II Trial of Berubicin for the Treatment of Central Nervous System Lymphoma

CNS Pharmaceuticals Initiates P-Ib/II Trial of Berubicin for the Treatment of Central Nervous System Lymphoma

January 13, 2023

Top COVID-19 Deals (Part I): Biopharma Drug Development

Top COVID-19 Deals (Part I): Biopharma Drug Development

April 17, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us